Activity Provided By:

The France Foundation and the American Society for Transplantation and Cellular Therapy

Identification of Relapsed ALL

Overview / Abstract:	Target Audience The target audience for this initiative includes hematology/oncology physicians and other members of the multidisciplinary cancer care team involved in the management of patients with acute lymphocytic leukemia. Program Overview This activity is the first in a series of four modules on relapsed/refractory acute lymphocytic leukemia (ALL). Module 1 focuses on identification of relapsed ALL. This education is presented by Dr. Reshma Ramlal from the University of Kentucky Markey Cancer Center. Dr. Ramlal presents a case study highlighting the progression of a patient diagnosed with relapsed/refractory ALL. Learning Objectives Upon completion of this activity, participants should be better able to: Identify Relapsed ALL Collaborate and communicate across disciplines for patient-centered care for their ALL patients
Expiration	Jun 14, 2023
Discipline(s)	Physician CME
Format	Online
Credits / Hours	0,5
Accreditation	ACCME
Presenters / Authors / Faculty	Presenting Faculty Reshma Ramlal, MD, FACP Content Reviewer Kirsten Roblee, MHI, BSN, RN, OCN
Sponsors / Supporters / Grant Providers	Pfizer
Keywords / Search Terms	Relias LLC Relias, Free CME, leukemia Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map